Identification and characterization of mefloquine efficacy against JC virus in vitro

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 1840-1849

  Brickelmaier, Margot ^a   Lugovskoy, Alexey ^a   Kartikeyan, Ramya ^b   Reviriego Mendoza, Marta M ^b   Allaire, Norm ^a   Simon, Kenneth ^a   Frisque, Richard J ^b   Gorelik, Leonid ^a  

^a BIOGEN   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEFLOQUINE; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL TYPE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA REPLICATION; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENCY; DRUG SCREENING; FETUS; GLIA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; JC VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QUANTITATIVE ANALYSIS; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

ANTIVIRAL AGENTS; ASTROCYTES; CELL LINE, TRANSFORMED; CELLS, CULTURED; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MEFLOQUINE; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; NEUROGLIA; SIMIAN VIRUS 40; VIRUS REPLICATION;

EID: 66149083981     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01614-08     Document Type: Article

References (61)

1. Aksamit, A. J. 2001. Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J. Neurovirol. 7:386-390. (Pubitemid 32894247)
2. Andrei, G., R. Snoeck, M. Vandeputte, and E. De Clercq. 1997. Activities of various compounds against murine and primate polyomaviruses. Antimicrob. Agents Chemother. 41:587-593. (Pubitemid 27098409)
3. Atwood, W. J. 2001. A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy. J. Neurovirol. 7:307-310. (Pubitemid 32894233)
4. Atwood, W. J., L. Wang, L. C. Durham, K. Amemiya, R. G. Traub, and E. O. Major. 1995. Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells. J. Neurovirol. 1:40-49.
5. Basco, L. K., C. Gillotin, F. Gimenez, R. Farinotti, and J. Le Bras. 1992. In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum. Br. J. Clin. Pharmacol. 33:517-520.
6. Baudry, S., Y. T. Pham, B. Baune, S. Vidrequin, C. Crevoisier, F. Gimenez, and R. Farinotti. 1997. Stereoselective passage of mefloquine through the blood-brain barrier in the rat. J. Pharm. Pharmacol. 49:1086-1090. (Pubitemid 27496722)
7. Berger, J. R. 2000. Progressive multifocal leukoencephalopathy. Curr. Treat. Options Neurol. 2:361-368.
8. Berger, J. R., and E. O. Major. 1999. Progressive multifocal leukoencephalopathy. Semin. Neurol. 19:193-200. (Pubitemid 29477592)
9. Bianchetti, G., S. Billy, V. Ascalone, S. Saivin, G. Houin, and P. Rosenzweig. 1996. Multicenter studies on the pharmacokinetic profile of sustained-release oral diltiazem (300 mg) after once a day repeated administration: influence of age. Int. J. Clin. Pharmacol. Ther. 34:195-201. (Pubitemid 26148679)
10. Bossolasco, S., G. Calori, F. Moretti, A. Boschini, D. Bertelli, M. Mena, S. Gerevini, A. Bestetti, R. Pedale, S. Sala, S. Sala, A. Lazzarin, and P. Cinque. 2005. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin. Infect. Dis. 40:738-744. (Pubitemid 40381351)
11. Bourahla, A., C. Martin, F. Gimenez, V. Singhasivanon, P. Attanath, A. Sabchearon, T. Chongsuphajaisiddhi, and R. Farinotti. 1996. Stereoselective pharmacokinetics of mefloquine in young children. Eur. J. Clin. Pharmacol. 50:241-244. (Pubitemid 26164718)
12. Bregante, M. A., J. J. Aramayona, L. J. Fraile, M. A. Garcia, and C. Solans. 2000. Diltiazem blood pharmacokinetics in the pregnant and non-pregnant rabbit: maternal and foetal tissue levels. Xenobiotica 30:831-841.
13. Brocks, D. R., and R. Mehvar. 2003. Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs. Clin. Pharmacokinet. 42:1359-1382. (Pubitemid 38045841)
14. Brooks, B. R., and D. L. Walker. 1984. Progressive multifocal leukoencephalopathy. Neurol. Clin. 2:299-313.
15. Chapagain, M. L., S. Verma, F. Mercier, R. Yanagihara, and V. R. Nerurkar. 2007. Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A. Virology 364:55-63. (Pubitemid 46829276)
16. Cinque, P., S. Bossolasco, A. M. Brambilla, A. Boschini, C. Mussini, C. Pierotti, A. Campi, S. Casari, D. Bertelli, M. Mena, and A. Lazzarin. 2003. The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature. J. Neurovirol. 9(Suppl. 1):73-80. (Pubitemid 36656475)
17. Cinque, P., I. J. Koralnik, and D. B. Clifford. 2003. The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J. Neurovirol. 9(Suppl. 1):88-92. (Pubitemid 36656477)
18. Clifford, D. B., C. Yiannoutsos, M. Glicksman, D. M. Simpson, E. J. Singer, P. J. Piliero, C. M. Marra, G. S. Francis, J. C. McArthur, K. L. Tyler, A. C. Tselis, and N. E. Hyslop. 1999. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52:623-625. (Pubitemid 29075615)
19. Crawford, L., and E. Harlow. 1982. Uniform nomenclature for monoclonal antibodies directed against virus-coded proteins of simian virus 40 and polyoma virus. J. Virol. 41:709.
20. Crowder, C. D., K. A. Gyure, C. B. Drachenberg, J. Werner, R. E. Morales, H. H. Hirsch, and E. Ramos. 2005. Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. Am. J. Transplant. 5:1151-1158. (Pubitemid 40571268)
21. De Luca, A., A. Ammassari, P. Pezzotti, P. Cinque, J. Gasnault, J. Berenguer, S. Di Giambenedetto, A. Cingolani, Y. Taoufik, P. Miralles, C. M. Marra, and A. Antinori. 2008. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS 22:1759-1767.
22. Eckhoff, C., and C. C. Willhite. 1997. Embryonic delivered dose of isotretinoin (13-cis-retinoic acid) and its metabolites in hamsters. Toxicol. Appl. Pharmacol. 146:79-87.
23. Elphick, G. F., W. Querbes, J. A. Jordan, G. V. Gee, S. Eash, K. Manley, A. Dugan, M. Stanifer, A. Bhatnagar, W. K. Kroeze, B. L. Roth, and W. J. Atwood. 2004. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380-1383. (Pubitemid 39532516)
24. Frisque, R. J., G. L. Bream, and M. T. Cannella. 1984. Human polyomavirus JC virus genome. J. Virol. 51:458-469. (Pubitemid 14091437)
25. Frye, S., C. Trebst, U. Dittmer, H. Petry, M. Bodemer, G. Hunsmann, T. Weber, and W. Luke. 1997. Efficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response. J. Virol. Methods 63:81-92.
26. Fukuda, M., K. Kitaichi, F. Abe, Y. Fujimoto, K. Takagi, K. Takagi, T. Morishima, and T. Hasegawa. 2005. Altered brain penetration of diclofenac and mefenamic acid, but not acetaminophen, in Shiga-like toxin II-treated mice. J. Pharmacol. Sci. 97:525-532. (Pubitemid 40628530)
27. Gasnault, J., P. Kousignian, M. Kahraman, J. Rahoiljaon, S. Matheron, J. F. Delfraissy, and Y. Taoufik. 2001. Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring. J. Neurovirol. 7:375-381. (Pubitemid 32894245)
28. Gasnault, J., Y. Taoufik, C. Goujard, P. Kousignian, K. Abbed, F. Boue, E. Dussaix, and J. F. Delfraissy. 1999. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. J. Neurovirol. 5:421-429. (Pubitemid 29391123)
29. Glazko, A. J. 1966. Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition. Ann. Phys. Med. (Suppl.):23-36.
30. Groothuis, D. R., H. Benalcazar, C. V. Allen, R. M. Wise, C. Dills, C. Dobrescu, V. Rothholtz, and R. M. Levy. 2000. Comparison of cytosine arabinoside delivery to rat brain by intravenous, intrathecal, intraventricular and intraparenchymal routes of administration. Brain Res. 856:281-290. (Pubitemid 30085537)
31. Hall, C. D., U. Dafni, D. Simpson, D. Clifford, P. E. Wetherill, B. Cohen, J. McArthur, H. Hollander, C. Yainnoutsos, E. Major, L. Millar, J. Timpone, et al.. 1998. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N. Engl. J. Med. 338:1345-1351.
32. Hirsch, H. H., C. B. Drachenberg, J. Steiger, and E. Ramos. 2006. Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and management. Adv. Exp. Med. Biol. 577:160-173.
33. Jones, R., G. Kunsman, B. Levine, M. Smith, and C. Stahl. 1994. Mefloquine distribution in postmortem cases. Forensic Sci. Int. 68:29-32. (Pubitemid 24292355)
34. Khan, A. A., J. G. Villablanca, C. P. Reynolds, and V. I. Avramis. 1996. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation. Cancer Chemother. Pharmacol. 39:34-41.
35. Knowles, W. A. 2006. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv. Exp. Med. Biol. 577:19-45.
36. Liu, C. K., A. P. Hope, and W. J. Atwood. 1998. The human polyomavirus, JCV, does not share receptor specificity with SV40 on human glial cells. J. Neurovirol. 4:49-58. (Pubitemid 28081578)
37. Lopez, J. A., E. Nassif, P. Vannicola, J. G. Krikorian, and R. P. Agarwal. 1985. Central nervous system pharmacokinetics of high-dose cytosine arabinoside. J. Neurooncol. 3:119-124. (Pubitemid 15001545)
38. Major, E. O., A. E. Miller, P. Mourrain, R. G. Traub, E. de Widt, and J. Sever. 1985. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. USA 82:1257-1261. (Pubitemid 15100534)
39. Marra, C. M., N. Rajicic, D. E. Barker, B. A. Cohen, D. Clifford, M. J. Donovan Post, A. Ruiz, B. C. Bowen, M. L. Huang, J. Queen-Baker, J. Andersen, S. Kelly, and S. Shriver. 2002. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16:1791-1797.
40. Mindermann, T., W. Zimmerli, Z. Rajacic, and O. Gratzl. 1993. Penetration of fusidic acid into human brain tissue and cerebrospinal fluid. Acta Neurochir. (Wien) 121:12-14.
41. Mu, J. Y., Z. H. Israili, and P. G. Dayton. 1975. Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30,090. Drug Metab. Dispos. 3:198-210.
42. Murakami, Y., and J. Hurwitz. 1993. DNA polymerase alpha stimulates the ATP-dependent binding of simian virus tumor T antigen to the SV40 origin of replication. J. Biol. Chem. 268:11018-11027. (Pubitemid 23162288)
43. O'Hara, B. A., and W. J. Atwood. 2008. Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus. Virus Res. 132:97-103.
44. Padgett, B. L., C. M. Rogers, and D. L. Walker. 1977. JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: additional biological characteristics and antigenic relationships. Infect. Immun. 15:656-662. (Pubitemid 8045504)
45. Padgett, B. L., D. L. Walker, G. M. ZuRhein, R. J. Eckroade, and B. H. Dessel. 1971. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet i:1257-1260.
46. Padgett, B. L., D. L. Walker, G. M. ZuRhein, A. E. Hodach, and S. M. Chou. 1976. JC papovavirus in progressive multifocal leukoencephalopathy. J. Infect. Dis. 133:686-690.
47. Pham, Y. T., F. Nosten, R. Farinotti, N. J. White, and F. Gimenez. 1999. Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Int. J. Clin. Pharmacol. Ther. 37:58-61. (Pubitemid 29043398)
48. Pho, M. T., A. Ashok, and W. J. Atwood. 2000. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol. 74:2288-2292. (Pubitemid 30091483)
49. Randhawa, P., F. Baksh, N. Aoki, D. Tschirhart, and S. Finkelstein. 2001. JC virus infection in allograft kidneys: analysis by polymerase chain reaction and immunohistochemistry. Transplantation 71:1300-1303.
50. Riffkin, C. D., R. Chung, D. M. Wall, J. R. Zalcberg, A. F. Cowman, M. Foley, and L. Tilley. 1996. Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine. Biochem. Pharmacol. 52:1545-1552. (Pubitemid 26375460)
51. Romsing, J., D. Ostergaard, T. Senderovitz, D. Drozdziewicz, J. Sonne, and G. Ravn. 2001. Pharmacokinetics of oral diclofenac and acetaminophen in children after surgery. Paediatr. Anaesth. 11:205-213. (Pubitemid 32195198)
52. Rush, T. S., III, J. A. Grant, L. Mosyak, and A. Nicholls. 2005. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. J. Med. Chem. 48:1489-1495. (Pubitemid 40364556)
53. Seelig, A. 2007. The role of size and charge for blood-brain barrier permeation of drugs and fatty acids. J. Mol. Neurosci. 33:32-41. (Pubitemid 47574956)
54. Shitrit, D., L. Nirit, S. I. Shiran, G. Izbicki, D. Sofer, M. Eldad, and M. R. Kramer. 2003. Progressive multifocal leukoencephalopathy in a lung transplant recipient. J. Heart Lung Transplant. 22:946-950. (Pubitemid 36945495)
55. Stevens, R. E., J. Konsil, S. S. Verrill, P. Roy, P. B. Desai, D. H. Upmalis, and F. L. Cone. 2002. Bioavailability study of a 1200 mg miconazole nitrate vaginal ovule in healthy female adults. J. Clin. Pharmacol. 42:52-60. (Pubitemid 34038370)
56. Turnidge, J. 1999. Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. Int. J. Antimicrob. Agents 12(Suppl. 2):S23-S34.
57. U.S. Pharmacopeia. 2005. USP dictionary of USAN and international drug names. U.S. Pharmacopeia, Rockville, MD.
58. Vacante, D. A., R. Traub, and E. O. Major. 1989. Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region. Virology 170:353-361. (Pubitemid 19162551)
59. Weiss, S. M., K. Benwell, I. A. Cliffe, R. J. Gillespie, A. R. Knight, J. Lerpiniere, A. Misra, R. M. Pratt, D. Revell, R. Upton, and C. T. Dourish. 2003. Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease. Neurology 61:S101-S106. (Pubitemid 37505558)
60. Wessel, R., J. Schweizer, and H. Stahl. 1992. Simian virus 40 T-antigen DNA helicase is a hexamer which forms a binary complex during bidirectional unwinding from the viral origin of DNA replication. J. Virol. 66:804-815.
61. Zhang, J. H., T. D. Chung, and K. R. Oldenburg. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4:67-73. (Pubitemid 29278954)